Pharmacists Seek Overtime Pay from CVS Class Action Suit

Article

CVS has been slapped with a federal class action suit, after a former assistant pharmacist for several stores reported that hourly paid pharmacists were not receiving time-and-a-half pay for working more than 40 hours per week.

CVS has been slapped with a federal class action suit, after a former assistant pharmacist for several stores reported that hourly paid pharmacists were not receiving time-and-a-half pay for working more than 40 hours per week.

Now, more than 1000 pharmacists in the Philadelphia area may be eligible to receive back payment under the federal complaints, The Pennsylvania Record reported.

Junius Baugh, the lead plaintiff in the complaint, accused CVS of violating the Fair Labor Standards Act, the Pennsylvania Minimum Wage Act, and the Pennsylvania Wage Payment and Collection Law. Baugh worked as a subordinate pharmacist from 2011 to 2012 and racked up hours filling in for sick or absent pharmacists, the complaint stated.

Baugh claimed that a typical work week for hourly paid pharmacists was between 40 and 50 hours a week, and instead of receiving $58.93 for an overtime shift, he should have received $88.40 an hour for his overtime work, The Pennsylvania Record reported. The claim stated that Baugh had worked 100 to 130 hours in a 2-week pay period.

The 1000 potential plaintiffs would have served as subordinate or floater pharmacists who worked overtime at CVS in the October 2011 and October 2012 period, according to the claim.

Related Videos
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
Image credit: motortion | stock.adobe.com - Young depressed woman talking to lady psychologist during session, mental health
Image credit:  JPC-PROD | stock.adobe.com - Choosing method of contraception : Birth control pills, an injection syringe, condom, IUD-method, on grey
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
Health care provider examining MRI images of patient with multiple sclerosis -- Image credit: New Africa | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.